Application of imaging methods to live animals and humans provides non-invasive biomarkers of disease to be used for disease detection and monitor therapeutic efficacy of new medications, or to follow the biodistribution and pharmacokinetics of new medications. Research includes custom programming for automating detection methods and improving throughput and accuracy of quantitative imaging results.
The radiology department at the University of Nebraska Medical Center (UNMC) is an NIH National Cancer Institute qualified Center of Quantitative Imaging Excellent site (CQIE). The CQIE program certifies university-imaging programs for participation in multicenter research trials that use quantitative imaging. The CQIE program establishes benchmarks for quality and consistency in quantitative imaging involving PET, MRI and CT protocols. The requirements were designed to promote standardization and harmonization of imaging data in multicenter clinical trials; this also includes an annual re-evaluation process to qualify scanners and site imaging capabilities. This designation is recognition of the high quality of medical imaging performed at UNMC and its affiliated institutions.
For additional information, please contact Dr. Thomas Lane (firstname.lastname@example.org) or Marie Witthoft (email@example.com)
Bioimaging Core Facility
- Examples of Results
- Clinical Research